Clinical Trial Supplies Market Size to grow by USD 1312.9 million between 2024-2028
According to a research report “ Clinical Trial Supplies Market” by End-user (Pharmaceutical industry, Biologics industry, Medical device industry) Type (Phase III, Phase II, Phase IV and BE/BA studies, Phase I) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 1312.9 million, at a CAGR of over 8.65% during the forecast period. The biopharmaceutical sector, encompassing biologics and pharmaceutical manufacturers and suppliers, experiences robust growth, fueled by innovation and investor interest. Biologics pioneers, suppliers, and financiers are invigorated by the industry's expanding profitability. The pharmaceutical industry's evolution towards biopharmaceuticals for drug discovery is driving market growth, with new global entrants introducing novel biosimilars and innovative drugs, particularly in areas like oncology, neurology, diabetes, and immunology, representing approximately 70% of potential medicines in development. This sector's potential to address previously untreatable conditions significantly contributes to its significance in the healthcare landscape.
Browse market data tables, figures, and in-depth TOC on “Clinical Trial Supplies Market” by End-user (Pharmaceutical industry, Biologics industry, Medical device industry) Type (Phase III, Phase II, Phase IV and BE/BA studies, Phase I) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By End-user, the Pharmaceutical industry segment is projected to dominate the market size in 2024
The Clinical Trial Supplies Market encompasses essential resources required for the successful execution of clinical trials. These supplies include, but are not limited to, investigational medicinal products, placebos, laboratory kits, and packaging materials. Market growth is driven by the increasing number of clinical trials, regulatory compliance, and technological advancements in trial design and execution. Companies are investing in innovative solutions to streamline supply chain management and improve trial efficiency.
By Type, Phase III segment is expected to hold the largest market size for the year 2024
The Clinical Trial Supplies Market encompasses a wide range of products and services essential for the successful execution of clinical trials. These include, but are not limited to, trial kits, investigational medicinal products, laboratory services, and packaging and labeling solutions. Market growth is driven by the increasing number of clinical trials, regulatory compliance, and advancements in technology. Strategic partnerships and collaborations are key strategies adopted by market players to expand their reach and enhance their offerings.
North America is forecasted to hold the largest market size by region in 2024
The Clinical Trial Supplies Market represents a significant business opportunity for industry participants, driven by the increasing demand for new and innovative pharmaceutical products. Key market drivers include regulatory compliance, rising research and development expenditures, and the growing preference for outsourcing clinical trial services. Market players focus on enhancing their offerings through strategic collaborations, product innovations, and geographic expansions to capture a larger market share.
The Clinical Trial Supplies Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Clinical Trial Supplies Market encompasses a wide range of products and services essential for conducting clinical trials in various therapeutic areas, including Cancer, Cardiovascular Disease, Oncology, and Biologics & Biosimilar Drugs. These trials involve the distribution of Pharmaceutical Drugs, Biological Drugs, and Medical Devices, which often require specialized handling, such as Cold Chain Distribution. The prevalence of diseases like Cancer drives the demand for new drugs and industrial collaborations, leading to an increase in registered clinical trials. Key stakeholders include Clinical Research Organizations (CROs), regulatory bodies, and subjects. The success of clinical research activities hinges on factors like drug approval, follow-up rates, and buying behavior. Biologics, including proteins, vaccines, and cell therapies, play a significant role in the market due to their increasing use in treating complex diseases. Biosimilar drugs offer cost-effective alternatives to branded biologics, expanding the market's scope. Effective regulatory support is crucial in ensuring the safety, efficacy, and quality of clinical trial supplies. The market's growth is influenced by the increasing incidence of diseases, technological advancements, and regulatory requirements.
Market Research Overview
The Clinical Trial Supplies Market encompasses a wide range of products and services required for conducting clinical trials on vaccines, pharmaceutical drugs, medical devices, and blood products for various diseases, including rare ones. The market caters to the needs of subjects, requiring skilled laborers, regulatory support, and adherence to Good Clinical Practices. Key stakeholders include Clinical Research Organizations (CROs), pharmaceutical companies, and healthcare logistics providers. The market includes supplies for storage and delivery of vaccines, drugs, and devices, as well as packaging, labeling, and manufacturing processes. Outsourcing of clinical trial supplies has become common due to the complexities involved in drug development, especially for new drugs in Oncology, Genetics and biotechnology, and Rare Diseases. Limitations include the prevalence of chronic diseases like Cardiovascular disease and Cancer, which require high follow-up rates, cold chain capabilities for storing sensitive drugs like Insulin and Hormones, and the hindrance posed by the incidence of diseases and the need for industrial collaborations. The market also includes supplies for blinding, biosimilars, and biologics & biosimilar drugs. Buying behavior is influenced by factors like drug approval, manufacturing, and cold chain distribution capabilities.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
